The Food and Drug Administration cleared Heartflow's technology to quantify coronary plaque and the platform is now available, the company said.

Dr. Peder Myhre: Welcome listeners to this week's issue of Circulation on the Run, the week of September 23. I am Dr. Peder ...

It can reveal plaque in arteries, offering a more precise estimate of a person’s risk of heart disease. Yet the test remains ...

Retinal microvascular changes detected by OCT-A may provide details for earlier diagnosis of coronary artery stenosis.

American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine (ACNM) have issued a new clinical guideline for 18F-flurpiridaz ...

Noninvasive retinal scans may flag underlying subclinical coronary atherosclerosis, according to a retrospective study in healthy Korean volunteers.

Heart attack rates are down for older adults, but they’re actually up for people under 40 — especially women. And younger ...